Primary Care Clinics in Wolfeboro, NH Accepting Medicare
6 Primary Care Clinics found. Showing 1 - 6
 Carroll County Gastroenterology, Inc. Internal Medicine - Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 29 Union St, Wolfeboro, NH 03894 Phone: 603-569-9681 Fax: 603-569-9384 |
Vlasta Zdrnja Md Pllc Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 240 S Main St, Wolfeboro, NH 03894 Phone: 603-569-0980 Fax: 603-569-0982 |
Internal Medicine Associates Of Wolfeboro Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 240 S Main St, Suite J, Wolfeboro, NH 03894 Phone: 603-569-7588 Fax: 603-569-7589 |
Jan Martensen Dc Phd Clinic/Center Medicare: Not Enrolled in Medicare Practice Location: 29 Mill St, Unit C4, Wolfeboro, NH 03894 Phone: 419-283-0234 |
Wolfeboro Family Medicine Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 240 S Main St, Medical Arts Building, Suite A, Wolfeboro, NH 03894 Phone: 603-569-7574 Fax: 603-569-7582 |
Hospitalist Physicians Of New Hampshire Pc Family Medicine Medicare: Medicare Enrolled Practice Location: 240 S Main St, Wolfeboro, NH 03894 Phone: 603-569-7500 |
News Archive
Researchers develop simpler and faster way to measure HDL's capacity to accept cholesterol
High-density lipoprotein cholesterol (HDL-C) is known as "good" cholesterol, because HDL particles removes excess cholesterol from arterial walls and transport them back to the liver.
Today's opinions and editorials
[I]t's virtually impossible to design a reform scheme that doesn't, in the early stages, involve at least some transfer of money away from the healthy and wealthy. The point of insurance is to pool risk, bringing in contributions from relatively healthy people, so that medical bills don't fall too heavily on the sick (Jonathan Cohn, 12/7).
Stateline: Detailing how a Medicaid 'blended rate' plan would work
House Republicans already have voted to convert Medicaid into a block grant program. ... The Obama administration has issued its alternative — a plan to cut $100 billion from federal Medicaid spending over the next decade.
FDA assigns new PDUFA date for Takeda's investigational type 2 diabetes therapy, alogliptin
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Global Research & Development Center, Inc., U.S., today announced that the company received notification from the U.S. Food and Drug Administration (FDA) that its review of investigational type 2 diabetes therapy alogliptin, and thus the fixed-dose combination therapy alogliptin/pioglitazone, will be delayed.
› Verified 1 days ago